Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-25

Clinical Trial Update: Clinical Assessment of Injectable Flowable Composite with Giomer Technology Vs High Viscosity Glass Ionomer Restorations in ART for Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing injectable Giomer-flowable composite with high-viscosity glass ionomer restorations in ART for cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • High Viscosity Glass Ionomer Restorations
  • Injectable Flowable Composite with Giomer Technology

Snippet

Sponsor: Cairo University | Conditions: Secondary Caries, Fracture Tooth | Phase 3 | Status: COMPLETED